Document is current
Any future updates will be listed below
-
Authors
Anees, Palapuravan
Saminathan, Anand
Rozmus, Ezekiel R.
Di, Anke
Malik, Asrar B. http://orcid.org/0000-0002-8205-7128
Delisle, Brian P. http://orcid.org/0000-0002-2146-327X
Krishnan, Yamuna http://orcid.org/0000-0001-5282-8852
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (DP1GM149751, 1R01GM147197-01, DP1GM149751)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS112139-01A1, 1R01NS112139-01A1)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R21HL161825-01A1, R21HL161825-01A1, R21HL161825-01A1)
Human Frontier Science Program (RGP0032/2022)
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-19-0003)
- License Information
-
More Information
Article History
Received: 8 January 2023
Accepted: 31 July 2023
First Online: 21 September 2023
Competing interests
: Y.K. is co-founder of Esya Inc. and MacroLogic Inc., which use DNA nanodevices for diagnostics and therapeutics, respectively. The other authors declare no competing interests.
